Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Peura

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Cleveland Clinic Journal of Medicine|June 28, 2002
Gastrointestinal safety and tolerability of nonselective nonsteroidal anti-inflammatory agents and cyclooxygenase-2-selective inhibitorsDavid A Peura
The American Journal of Medicine|October 14, 2004
Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complicationsDavid A Peura
Arthritis Research & Therapy|September 20, 2005
Balancing the gastrointestinal benefits and risks of nonselective NSAIDsDavid A Peura, Lawrence Goldkind
Gastroenterology|May 14, 2008
Control of gastric acid secretion in health and diseaseMitchell L Schubert, David A Peura
Therapeutic Advances in Gastroenterology|December 25, 2010
Evaluation and management of dyspepsiaR Christopher Harmon, David A Peura
Current Gastroenterology Reports|November 21, 2002
Helicobacter pylori-Associated DiseasesMichael K Sanders, David A Peura
Gastrointestinal Endoscopy Clinics of North America|September 28, 2011
The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the worldAndrew Y Wang, David A Peura
Therapeutics and Clinical Risk Management|November 21, 2015
Managing gastroesophageal reflux disease - comparative efficacy and outcomes of dexlansoprazole MRJeanetta W Frye, David A Peura
Expert Review of Gastroenterology & Hepatology|July 26, 2011
Dexlansoprazole MR for the management of gastroesophageal reflux diseaseBrian W Behm, David A Peura
Advances in Therapy|April 13, 2011
Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect?Pamela R Kushner, David A Peura
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Cleveland Clinic Journal of Medicine|June 28, 2002
Gastrointestinal safety and tolerability of nonselective nonsteroidal anti-inflammatory agents and cyclooxygenase-2-selective inhibitorsDavid A Peura
The American Journal of Medicine|October 14, 2004
Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complicationsDavid A Peura
Arthritis Research & Therapy|September 20, 2005
Balancing the gastrointestinal benefits and risks of nonselective NSAIDsDavid A Peura, Lawrence Goldkind
Gastroenterology|May 14, 2008
Control of gastric acid secretion in health and diseaseMitchell L Schubert, David A Peura
Therapeutic Advances in Gastroenterology|December 25, 2010
Evaluation and management of dyspepsiaR Christopher Harmon, David A Peura
Current Gastroenterology Reports|November 21, 2002
Helicobacter pylori-Associated DiseasesMichael K Sanders, David A Peura
Gastrointestinal Endoscopy Clinics of North America|September 28, 2011
The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the worldAndrew Y Wang, David A Peura
Therapeutics and Clinical Risk Management|November 21, 2015
Managing gastroesophageal reflux disease - comparative efficacy and outcomes of dexlansoprazole MRJeanetta W Frye, David A Peura
Expert Review of Gastroenterology & Hepatology|July 26, 2011
Dexlansoprazole MR for the management of gastroesophageal reflux diseaseBrian W Behm, David A Peura
Advances in Therapy|April 13, 2011
Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect?Pamela R Kushner, David A Peura
Pageof 4